86.22.Z - Specialist medical practice activities
47.91.Z - Retail sale via mail order houses or via Internet
47.99.Z - Other retail sale not in stores, stalls or markets
68.20.Z - Rental and operating of own or leased real estate
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
85.59.B - Other out-of-school forms of education, not elsewhere classified
85.60.Z - Educational support activities
86.21.Z - General medical practice activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,5 | 0,1 | 0,1 | 17,2 |
Gross profit (loss) | 0,5 | 0 | 0 | 30 |
EBITDA | 0,5 | 0,2 | 0,4 | 68,4 |
Short time liabilities | 0,3 | 0,3 | 0,3 | 1,8 |
Other operating costs | 0 | 0 | 0 | -14,2 |
Equity capital | 0,6 | 0,6 | 0,7 | 5,9 |
Operating profit (EBIT) | 0,5 | 0,1 | 0,1 | 19,3 |
Assets | 1,7 | 1,7 | 1,8 | 10 |
Net profit (loss) | 0,4 | 0 | 0 | 20,8 |
Cash | 0,3 | 0,1 | 0,3 | 185,1 |
Net income from sale | 2 | 1,4 | 1,7 | 18,3 |
Liabilities and provisions for liabilities | 1,1 | 1 | 1,1 | 12,7 |
Working assets | 0,6 | 0,4 | 0,6 | 69 |
Other income costs | 0 | 0 | 0 | 547,4 |
Depreciation | 0 | 0,2 | 0,3 | 93,6 |
% | % | % | p.p. | |
Profitability of capital | 68,2 | 4,8 | 5,5 | 0,7 |
Equity capital to total assets | 36,3 | 38,8 | 37,4 | -1,4 |
Gross profit margin | 23,4 | 2,4 | 2,7 | 0,3 |
EBITDA Margin | 23,4 | 17,2 | 24,5 | 7,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 62 | 69 | 60 | -9 |
Current financial liquidity indicator | 1.7411932945251465 | 1.3834446668624878 | 2.2953829765319824 | 0,9 |
Net dept to EBITDA | 1.0132205486297607 | 2.8086278438568115 | 1.3433423042297363 | -1,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane